We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Brainsway Ltd. Sponsored ADR (BWAY - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Brainsway Ltd. Sponsored ADR is a member of our Medical group, which includes 998 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Brainsway Ltd. Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BWAY's full-year earnings has moved 13% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BWAY has moved about 17% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 4.9% on average. This means that Brainsway Ltd. Sponsored ADR is outperforming the sector as a whole this year.
Another stock in the Medical sector, Cardinal Health (CAH - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 39.9%.
The consensus estimate for Cardinal Health's current year EPS has increased 3.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Brainsway Ltd. Sponsored ADR belongs to the Medical - Products industry, a group that includes 83 individual companies and currently sits at #153 in the Zacks Industry Rank. On average, this group has gained an average of 3.7% so far this year, meaning that BWAY is performing better in terms of year-to-date returns.
In contrast, Cardinal Health falls under the Medical - Dental Supplies industry. Currently, this industry has 14 stocks and is ranked #29. Since the beginning of the year, the industry has moved -0.9%.
Investors with an interest in Medical stocks should continue to track Brainsway Ltd. Sponsored ADR and Cardinal Health. These stocks will be looking to continue their solid performance.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Are Medical Stocks Lagging Brainsway (BWAY) This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Brainsway Ltd. Sponsored ADR (BWAY - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.
Brainsway Ltd. Sponsored ADR is a member of our Medical group, which includes 998 different companies and currently sits at #6 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different groups, measuring the average Zacks Rank of the individual stocks within the sector to gauge the strength of each group.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Brainsway Ltd. Sponsored ADR is currently sporting a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for BWAY's full-year earnings has moved 13% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.
According to our latest data, BWAY has moved about 17% on a year-to-date basis. Meanwhile, stocks in the Medical group have lost about 4.9% on average. This means that Brainsway Ltd. Sponsored ADR is outperforming the sector as a whole this year.
Another stock in the Medical sector, Cardinal Health (CAH - Free Report) , has outperformed the sector so far this year. The stock's year-to-date return is 39.9%.
The consensus estimate for Cardinal Health's current year EPS has increased 3.2% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Brainsway Ltd. Sponsored ADR belongs to the Medical - Products industry, a group that includes 83 individual companies and currently sits at #153 in the Zacks Industry Rank. On average, this group has gained an average of 3.7% so far this year, meaning that BWAY is performing better in terms of year-to-date returns.
In contrast, Cardinal Health falls under the Medical - Dental Supplies industry. Currently, this industry has 14 stocks and is ranked #29. Since the beginning of the year, the industry has moved -0.9%.
Investors with an interest in Medical stocks should continue to track Brainsway Ltd. Sponsored ADR and Cardinal Health. These stocks will be looking to continue their solid performance.